Cite
Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
MLA
Kumagai, K., et al. “Effects of Once-Monthly Minodronate versus Risedronate in Osteoporosis Patients with Rheumatoid Arthritis: A 12-Month Randomized Head-to-Head Comparison.” Osteoporosis International, vol. 29, no. 7, July 2018, pp. 1637–42. EBSCOhost, https://doi.org/10.1007/s00198-018-4494-9.
APA
Kumagai, K., Harigane, K., Kusayama, Y., Tezuka, T., Choe, H., Inaba, Y., & Saito, T. (2018). Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison. Osteoporosis International, 29(7), 1637–1642. https://doi.org/10.1007/s00198-018-4494-9
Chicago
Kumagai, K., K. Harigane, Y. Kusayama, T. Tezuka, H. Choe, Y. Inaba, and T. Saito. 2018. “Effects of Once-Monthly Minodronate versus Risedronate in Osteoporosis Patients with Rheumatoid Arthritis: A 12-Month Randomized Head-to-Head Comparison.” Osteoporosis International 29 (7): 1637–42. doi:10.1007/s00198-018-4494-9.